Objective-Abdominal aortic aneurysm (AAA) has high mortality rate when ruptured, but currently, there is no proven pharmacological therapy for AAA because of our poor understanding of its pathogenesis. The current study explored a novel role of smooth muscle cell (SMC) BMAL1 (brain and muscle Arnt-like protein-1)-a transcription factor known to regulate circadian rhythm-in AAA development. Approach and Results-SMC-selective deletion of BMAL1 potently protected mice from AAA induced by (1) MR (mineralocorticoid receptor) agonist deoxycorticosterone acetate or aldosterone plus high salt intake and (2) angiotensin II infusion in hypercholesterolemia mice. Aortic BMAL1 was upregulated by deoxycorticosterone acetate-salt, and deletion of BMAL1 in SMCs selectively upregulated TIMP4 (tissue inhibitor of metalloproteinase 4) and suppressed deoxycorticosterone acetate-salt-induced MMP (matrix metalloproteinase) activation and elastin breakages. Moreover, BMAL1 bound to the Timp4 promoter and suppressed Timp4 transcription. Conclusions-These results reveal an important, but previously unexplored, role of SMC BMAL1 in AAA. Moreover, these results identify TIMP4 as a novel target of BMAL1, which may mediate the AAA protective effect of SMC BMAL1 deletion. Visual Overview-An online visual overview is available for this article.
A bdominal aortic aneurysm (AAA) is defined as a localized abnormal dilation of the abdominal aorta that exceeds the normal diameter by >50% and is the most common form of aortic aneurysm. AAA affects 4% to 8% men >60 years of age and accounts for ≈2% of all deaths in Western countries. 1 Patients harboring an AAA are often asymptomatic until the aneurysm ruptures, which results in severe morbidity and a high incidence of mortality. In particular, there is no drug of demonstrated efficacy for this devastating disease, and open or endovascular surgery is the only option for patients with AAA. 2 Thus, there is an urgent clinical need to decipher molecular mechanisms to identify therapeutic targets to develop effective drugs to treat AAA.
See accompanying editorial on page 982
We reported recently that administration of MR (mineralocorticoid receptor) agonists, deoxycorticosterone acetate (DOCA), or aldosterone, in combination with high salt to WT (wild type) C57BL/6 male mice potently induced AAA formation and rupture in an age-dependent manner. 3 These findings suggest high salt intake and high aldosterone are 2 factors for promotion of AAA. Some human studies support this notion: 4, 5 An analysis of drug modulation of AAA growth through 25 years of surveillance in 1269 patients demonstrated a strong association between MR blockers and slowed AAA progression 4 and reported high salt intake was associated with increased prevalence of AAA and larger aortic diameter in older men. 5 However, the mechanism that underlies DOCA or aldosterone plus salt-induced AAA is largely unknown.
BMAL1 (brain and muscle ARNT-like protein-1)-a basic helix-loop-helix transcription factor and an obligatory core clock gene-is essential for normal circadian rhythmicity in physiology and behavior. 6 Global deletion of BMAL1 causes immediate and complete loss of circadian rhythmicity in mice. 7 Interestingly, aortic dissection and rupture exhibit circadian variability, 8 suggesting a potential involvement of the clock gene in AAA. Moreover, accumulating evidence suggests that, in addition to regulating circadian rhythm, BMAL1 is involved in vascular pathologies, 9 including flow-dependent vascular remodeling, 10 aortic vascular stiffness, 11 transplant arteriosclerosis, 12 and increased superoxide and endothelial NO synthase uncoupling in the aorta. 13 However, whether BMAL1 is involved in AAA has not yet been investigated.
Vascular smooth muscle cells (VSMC) play a critical role in 3 aortic aneurysm hallmark processes: degradation of elastin and extracellular matrix protein, loss of medium-layer smooth muscle cells (SMCs), and intense inflammatory cell infiltration.
14,15 SMC myosin and actin mutations have been linked to thoracic aortic aneurysm (TAA) development in humans. 16 To experimentally test the role of SMC BMAL1 in aortic aneurysm, we selectively deleted SMC BMAL1 and determined its effect on DOCA and salt (DOCA-salt)-or aldosterone and salt (Aldosalt)-induced AAA and angiotensin II (Ang II)-induced AAA in hypercholesterolemia mice. Here, we report our surprising finding that selective deletion of SMC BMAL1 provides effective protection from aortic aneurysm in 2 different AAA mouse models. Moreover, such protection was associated with selective upregulation of TIMP4 (tissue inhibitor of metalloproteinase 4), raising the possibility that TIMP4 contributes to the protection.
Materials and Methods

Animals
Ten-week-, 4-month-, or 8-to 10-month-old male C57BL/6, SM-Bmal1 ) were used for this study. SM-Bmal1 −/− mice were generated by crossing female Bmal1 flox/flox mice 17 (JAX stock No. 007668) with male smooth muscle-specific SM22α-Cre knockin mice 18 (JAX stock No. 006878). The genotyping methods and characterization of the SM-Bmal1
−/− mice were described previously. 19 Ten-week-old male C57BL/6 mice were purchased from the Jackson Laboratory (JAX stock 000664). All animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Kentucky.
General Experimental Protocols
The procedures for the DOCA-salt and Aldo-salt AAA mouse models and for the Ang II infusion-induced AAA in hypercholesterolemia mice were described previously. 3, 20 
Ultrasound Imaging
The procedures for using a high-resolution ultrasound imaging system (Vevo 2100, VisualSonics) to measure maximal intraluminal diameter of abdominal aortas were described previously. 3 Briefly, mice were laid supine on a heated table, and warmed ultrasound transmission gel was placed on the abdomen. Cine loops of 300 frames were acquired throughout the renal region of the abdominal aorta (short axis) and used to determine the maximal diameters of the abdominal aorta in the suprarenal region. Portal Triad (hepatic artery, hepatic vein, and bile duct) was used as anatomic marker to assess transverse images in the same location in each mouse.
Blood Pressure Measurement
The procedures for using a noninvasive tail-cuff method (Coda 8; Kent Scientific Corp) to measure blood pressure were described previously. 3 Briefly, blood pressure was measured before and 2 weeks after DOCA-salt or 3 weeks after Aldo-salt administration. Blood pressure was measured at the same time of day, 5 days a week on a 37°C heated stage, and the data collected during the last 3 days were used for analysis. Each day, mice were subjected to 10 preliminary and 10 recorded measurements, and a minimum of 5 measurements on each mouse was required for inclusion of data.
Definition and Quantification of Aortic Aneurysms
The definition of DOCA-salt-, Aldo-salt-, PCSK9 (protein convertase subtilisin/kexin type 9) adeno-associated virus (AAV)/diet/Ang II-induced AAA and TAA were defined as having at least a 50% increase in the maximal intraluminal and external diameters compared with the same region of the aorta in the control mice. The maximal intraluminal diameters of suprarenal abdominal aortas were quantified in vivo by ultrasound imaging. The maximal external diameters of descending thoracic aortas and abdominal aortas were quantified ex vivo under a microscope.
Plasma Sodium Measurement
Plasma sodium and potassium concentrations were measured by the VetScan i-STAT1 handheld analyzer (Abaxis) with I-STAT E3+ Cartridge (Cat No. 600-9004-25; Abaxis) according to the manufacturer's instructions.
In Situ Zymography and Gel Zymography
The procedures for in situ zymography were described previously. 3 For gel zymography, the whole aortas were isolated from SM-Bmal1 −/− mice and WT littermates administered with DOCA-salt dissected and incubated in a Krebs buffer for 24 hours at 37°C. The medium containing MMPs (matrix metalloproteinases) was collected, and proteins were resolved in an SDS-PAGE containing 2% gelatin (Cat No. G1890; Sigma-Aldrich). The gelatin zymogram gel was stained with GelCode Blue Safe Protein (Cat No. 1860983; ThermoFisher) and scanned for visualization of MMPs as described. 
Real-Time Polymerase Chain Reaction
The procedures for real-time polymerase chain reaction (PCR) were described previously. 3, 19, [22] [23] [24] [25] Briefly, aortic arch, descending aorta, suprarenal aorta, and infrarenal aorta, as well as whole aortas, were placed in Invitrogen RNAlater Stabilization Solution (Cat No. AM7021; Fisher). After removing the adventitia and endothelium, total RNA was extracted using an RNeasy mini-kit (Cat No. 74104; Qiagen) by following the manufacturer's instructions.
For cultured SMCs, BMAL1-deficient and WT aortic VSMCs were isolated from SM-Bmal1 −/− mice and WT littermates as described previously. 19, [23] [24] [25] The cDNA was synthesized by M-MLV reverse transcriptase (Cat No. 28025013; Invitrogen) using random hexamers. The primers used for amplification of mouse MR, Timp1, Timp2, Timp3, and Timp4 mRNAs were described in Table I in the online-only Data Supplement. The primers used for amplification of mouse Bmal1, Per1, Rev-erbA, Cry1, and 36B4 were described previously. 19, 26 All PCR primers were designed by Primer3Plus and were chosen only if they either crossed introns or flanked introns to eliminate potential genomic DNA contamination. The real-time PCR reactions were performed using a GoTaq G2 Flexi DNA polymerase with SYBR green (Cat No. M7801; Promega) in a BIO-RAD CFX96 Real-Time System. Two controls, 1 with no template and 1 with no reverse transcription, were included in each real-time PCR run to ensure the specificity of real-time PCR. Importantly, real-time PCR dissociation curve analysis was performed for all genes, and only the data that passed real-time PCR dissociation curve analysis were taken. All mRNA expressions were normalized to the 36B4 rRNA and quantified by a standard curve method.
Histological and Immunohistological Staining
The procedures for histological and immunohistological staining were described previously.
3,22
Tissue Chromatin Immunoprecipitation Assay
The procedures for tissue chromatin immunoprecipitation assay were described previously 19 and in materials in the online-only Data Supplement.
Cloning Mouse Timp4 Promoter
A mouse bacterial artificial chromosome clone containing the mouse Timp4 promoter was purchased from Invitrogen. A 2 kb of the Timp4 promoter was amplified by PCR using primers as described in Table  I in the online-only Data Supplement. The cloned Timp4 promoter was verified by DNA sequencing (ACGT, Inc) and subcloned into a pGL3-basic vector (Cat No. E1751; Promega) at KpnI and XhoI sites.
Timp4 Promoter Assay
The procedures for luciferase promoter assay were described previously. 19, 25 In particular, BMAL1-deficient and WT aortic VSMCs were isolated from SM-Bmal1 −/− and WT littermates as described previously. 19, [23] [24] [25] Cells were grown on a DMEM medium containing 10% (v/v) FBS until 70% confluence. Cells were then incubated with FBS-free medium overnight and were cotransfected with a pGl3-Timp4-promoter firefly luciferase construct and a pRL-SV40 renilla luciferase control vector (Cat No. E2231; Promega) using Lipofectamine-Plus reagent (Cat No. 15338100; Invitrogen). The Timp4 luciferase promoter activity was assayed by a modified dual luciferase enzyme assay as described.
19,25
ELISA of TIMP4 Protein
Protein was extracted by radioimmunoprecipitation assay buffer from snap-frozen aortas from 10-month-old male SM-bmal1 −/− mice and WT littermates administered with DOCA-salt for 3 weeks. The protein concentration was determined by a Pierce BCA Protein Assay kit (Cat No. PI23227; Fisher). The equal amount of protein was used to determine the TIMP4 protein level in the aorta extracts by a Mouse TIMP-4 DuoSet ELISA kit (Cat No. DY7667-05; R&D Systems) following the manufacturer's instruction.
Production and Injection of PCSK9.AAV
The production and injection of AAV into mice were described previously. 20 Briefly, AAVs (serotype 8) were produced by the Viral Vector Core at the University of Pennsylvania. These AAVs contained inserts expressing mouse PCSK9D377Y mutation (equivalent to human PCSK9D374Y gain-of-function mutation [referred to PCSK9.AAV in this article]). PCSK9.AAV was diluted in sterile PBS (2×10 11 AAVs in 200 µL) and was injected intraperitoneally (1×).
Statistical Analysis
All data were expressed as mean±SEM. Continuous data were assessed both visually and statistically for normality. Non-normally distributed data were log-transformed and reanalyzed for normality. Data were analyzed by unpaired Student t tests for 2 groups, by 1-way ANOVA for 1 group with multiple time point, by 2-way repeated measures ANOVA on time for longitudinal data with between-group factors of mouse genotype, or by 2-way ANOVA with between-group factors of mouse genotype, treatment, or aorta region. When difference existed between groups, a Bonferroni post hoc analysis was performed. For comparison of the incidence of TAA or AAA, χ 2 analysis was performed. P<0.05 was considered significant. P≥0.05 was considered nonsignificant.
Results
Deletion of BMAL1 in SMCs Potently Protected Mice From DOCA or Aldosterone Plus Salt-Induced AAA
We recently developed a novel SMC BMAL1 knockout mouse model (SM-Bmal1
−/− ) and demonstrated that SMC BMAL1 exerted a critical role in the normal amplitude and time-of-day variation in vasoconstriction and blood pressure circadian rhythm. 19 To define a role of SMC BMAL1 in AAA, we investigated Aldo-salt-induced AAA in 4-monthold SM-Bmal1 −/− mice and WT littermates. Ultrasound quantification of the intraluminal diameter of the abdominal aorta illustrated that Aldo-salt induced a time-dependent aortic dilation in WT mice, and this time-dependent aortic dilation was largely suppressed in SM-Bmal1 −/− mice ( Figure 1A ). Similarly, an increase in the external diameter of the abdominal aorta by Aldo-salt was also found in WT mice but not in SM-Bmal1 −/− mice ( Figure 1B ). Noticeably, 5 of 14 WT mice (36% incidence) developed AAA, and only 1 of 14 WT mice (7% incidence) also developed TAA, but none of SM-Bmal1 −/− mice developed either AAA or TAA ( Figure 1C and 1G left).
We also investigated whether deletion of BMAL1 in SMCs afforded protection from DOCA-salt-induced AAA in 4-month-old SM-Bmal1 −/− mice and WT littermates. We observed a similar protective effect of deleting BMAL1 in SMCs on DOCA-salt-induced aortic aneurysms. In particular, SM-Bmal1 −/− mice exhibited less increased external diameters of the abdominal and thoracic aorta ( Figure IA in the online-only Data Supplement), decreased the incidence of AAA, TAA, and aortic rupture ( Figure IB and IC in the online-only Data Supplement) compared with WT mice. Because the incidence and severity of AAA induced by DOCA-salt are age-dependent, 3 we investigated whether deletion of BMAL1 in SMCs was also effective in protecting mice from DOCA-salt-induced AAA in 8-month-old mice. The results show again that the increases in intraluminal diameters of abdominal aorta ( Figure 1D ), external diameters of abdominal and thoracic aorta ( Figure 1E ), and the incidence of AAA, TAA, and aortic rupture ( Figure 1F and 1G right) were all abolished in SM-Bmal1
−/− mice compared with that in WT littermates.
Deletion of BMAL1 in SMCs Had Minimal Effect on Renal Sodium Handling and Blood Pressure Changing in Response to DOCA or Aldosterone Plus Salt
To investigate the mechanisms by which deletion of BMAL1 in SMCs protects mice from DOCA-or Aldo-salt-induced AAA, we first tested the possibility that BMAL1 deletion in SMCs might affect renal sodium handling because high salt intake is required for DOCA-or aldosterone-induced AAA. 3 In the absence of DOCA-salt, there were no differences in kidney weight, length, urine volume at light phase and dark phase, and plasma sodium concentration at Zeitgeber time 5 and 17 between SM-Bmal1 −/− mice and WT littermates ( 
wk (A-C). Eight-month-old male SM-Bmal1
−/− mice (n=16) and WT littermates (n=16) were administered with DOCA-salt for 3 wk (D-F). A and D, Quantifications of maximal intraluminal diameters of abdominal aorta by ultrasound. B and E, Quantifications of maximal external diameters of the abdominal and thoracic aorta by microscopy. C and F, Incidences of abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA), and aortic aneurysm rupture. G, Representative pictures of the aorta with or without AAAs. Two-way repeated measure ANOVA followed by Bonferroni post hoc analysis was used for statistics in A and D. Unpaired t test was used for statistics in B and E. χ 2 was used for comparing AAA incidence in C and F. KO indicates knockout; and ns, nonsignificant. *P<0.05, ***P<0.001. plasma sodium concentrations were increased, whereas the level of plasma potassium was decreased to a similar extent in SM-Bmal1 −/− mice and WT littermates ( Figure 2E and 2F), suggesting that deletion of BMAL1 in SMCs has minimal effect on basal and DOCA-salt-induced electrolyte handling in the kidney.
We also measured blood pressure by a tail-cuff method in SM-Bmal1 −/− mice and WT littermates before and after DOCA-or Aldo-salt administration. Lower basal blood pressure was found in 4-month-old SM-Bmal1 −/− mice than that in WT littermates ( Figure 2G and 2H) , which is consistent with our previous results measured by a telemetry method. 19 However, regardless of their ages, both SM-Bmal1 −/− mice and WT littermates increased their blood pressures to a similar extent in response to DOCA-salt or Aldo-salt ( Figure 2G through 2I). Interestingly, there was no difference in basal blood pressure between 8-month-old SM-Bmal1 −/− mice and WT littermates ( Figure 2I ).
Deletion of BMAL1 in SMCs Had Minimal Effect on MR mRNA Expression in Abdominal Aorta
We then tested the possibility that BMAL1 deletion in SMCs may decrease MR expression in aorta and, therefore, protect mice from DOCA-or Aldo-salt-induced AAA as MR is increased in aged aortas, 27 SMC MR is involved in age-related hypertension, 28 and MR is required for DOCA-or Aldo-saltinduced AAA. 3 We determined aortic MR mRNA abundance in SM-Bmal1 −/− mice and WT littermates before and after administration with DOCA-salt for 7 days. First, DOCA-salt seemed to suppress MR mRNA expression in WT mice: a significant inhibition was found in the aortic arch and descending aorta, and a trend toward downregulation was found in the suprarenal and infrarenal aorta ( Figure IIA administration except for in descending aorta where deletion of SMC BMAL1 significantly decreased MR mRNA abundance.
Deletion of BMAL1 in SMCs Abolished
DOCA-Salt-Induced MMP Activation and Elastin Breakage in Abdominal Aorta
We investigated the effects of BMAL1 deletion in SMCs on DOCA-salt-induced elastin breakage because it is well recognized for its pivotal causal role in aortic dilation and AAA formation and rupture.
1,2 Verhoeff Van Gieson elastin staining ( Figure 3A ) and quantitative data ( Figure III in the online-only Data Supplement) demonstrated that DOCA-saltinduced elastin breakage, which is consistent with our previous results, 3 and deletion of BMAL1 in SMCs effectively prevented DOCA-salt-induced elastin breakage.
We then investigated the effect of BMAL1 deletion in SMCs on DOCA-salt-induced MMP activation because MMPs, in particular, MMP2 and MMP9, have been demonstrated to be critical for elastin breakage in AAA in animal models. 29 We used in situ zymography to determine MMP activity in tissue sections of abdominal aortas from SM-Bmal1 −/− mice and WT littermates administered with DOCA-salt for 7 days. In the absence of DOCA-salt, minimal MMP activity was detected in aortas from both SM-Bmal1 −/− mice and WT littermates. In the presence of DOCA-salt, however, a pronounced MMP activity was detected in aortas from WT littermates, which was consistent with our previous results 3 but not in SM-Bmal1 −/− mice ( Figure 3B ). This result indicates that deletion of BMAL1 in SMCs prevents mice from DOCA-salt-induced elastin breakage is associated with inhibition of MMP activity.
BMAL1 Deletion in SMCs Increased TIMP4 Expression in Abdominal Aorta
The protective effect of BMAL1 deletion in SMCs on AAA may be attributable to inhibiting/downregulating MMP2/ MMP9 or to activating/upregulating aortic TIMPs or both. To investigate which mechanisms operate in SM-Bmal1
−/− mice, we determined aortic MMP2 and MMP9 activities in SM-Bmal1 −/− mice and WT littermates administered with DOCA-salt for 7 days by gel zymography-a simple but sensitive method to detect MMP under a condition at which MMPs are dissociated from bound TIMPs. 21 Consistent with the result of in situ zymography ( Figure 3B ), DOCA-salt significantly increased proMMP2, MMP2, proMMP9, and MMP9 activities in WT mice ( Figure IV in the online-only Data Supplement). Surprisingly, in sharp contrast to the result of in situ zymography, deletion of BMAL1 in SMCs had minimal effect on DOCA-salt-induced proMMP2, MMP2, proMMP9, and MMP9 expression. In fact, under basal condition, a trend toward an increase in proMMP2, MMP2, and proMMP9 activities was found in SM-Bmal1 −/− mice relative to that in WT mice.
Because in gel zymography detects MMP activity under a condition that all MMPs, including proMMPs, are activated by SDS, the activity of MMPs detected by in-gel zymography is proportional to the abundance of MMP protein in samples regardless of whether they are active or inactive. 21 In contrast, in situ zymography is only to detect active MMPs. Thus, the different effects of deleting BMAL1 in SMCs on DOCA-salt-induced MMP activities between using gel zymography and using in situ zymography suggest that the activity of MMPs, but not the level of MMPs, is suppressed by the deletion of BMAL1 in SMCs. We, therefore, investigated the possibility that BMAL1 regulates TIMPs, which are the major endogenous cellular determinants of MMP activities. 30, 31 Four TIMPs (TIMP1, TIMP2, TIMP3, and TIMP4) have been identified and characterized in mammals, and all 4 TIMPs can inhibit active forms of all MMPs with distinct affinity and potency. 30, 31 To explore which TIMP is expressed in the aorta, responds to DOCA-salt, and is regulated by SMC BMAL1, we determined the mRNA abundance of all 4 Timps in aortas isolated from SM-Bmal1 −/− mice and WT littermates before and 7 days after DOCA-salt administration. Although all 4 Timp mRNA were present in mouse aorta, no significant differences were detected in Timp1 and Timp2 mRNA abundance before and after DOCA-salt administration or between SM-Bmal1 −/− mice and WT littermates ( Figure 4A and 4B) . In contrast, Timp3 mRNA was increased by DOCA-salt in both WT and SM-Bmal1 −/− mice, but deletion of BMAL1 in SMCs suppressed such DOCA-salt-induced Timp3 upregulation ( Figure 4C ). These results suggest that Timp3 may play a compensatory role in DOCA-salt-induced AAA and unlikely accounts for the protective effect of deletion of BMAL1 in SMCs on AAA.
Interestingly, Timp4 mRNA was upregulated in aortas from SM-Bmal1 −/− mice compared with WT littermates, and such upregulation was more obvious and significant at 7 days after DOCA-salt administration ( Figure 4D) . A similar and more dramatic result was also observed in aortas from SM-Bmal1 −/− mice compared with that in WT littermates at 21 days after DOCA-salt administration ( Figure 4E ), suggesting that Timp4 mRNA upregulation in SM-Bmal1 −/− mice was sustained. To investigate whether the Timp4 mRNA upregulation leads to increased protein, we also determined TIMP4 protein expression in aortas from SM-Bmal1 −/− mice and WT littermates administered with DOCA-salt for 21 days. Two distinct approaches were taken. First, TIMP4 protein in the isolated aortas was measured by ELISA. In agreement with Timp4 mRNA increase, the TIMP4 protein was upregulated in aortas from SM-Bmal1 −/− mice relative to that in WT littermates before and after DOCA-salt administration ( Figure 4F ). Second, isolated abdominal aortas were subjected to TIMP4 immunohistological staining. Again, a significant higher TIMP4 protein abundance was found in SM-Bmal1 −/− mice than that in WT littermates under basal and DOCA-salt conditions ( Figure 4G ). Of note, the increase in TIMP4 protein was mainly observed in the medium SMC layer of the vessel wall from SM-Bmal1 −/− mice relative to that in WT littermates, indicating a spatial correlation between SMC BMAL1 deletion and TIMP4 upregulation.
Because DOCA-salt causes infiltration of a large number of inflammatory cells into the aorta, 3 
BMAL1 Was Upregulated in Aorta by DOCA-Salt
It is clear that SMC BMAL1 is critically involved in DOCAor Aldo-salt-induced MMP activation, elastin breakage, and AAA formation, which probably involves TIMP4. However, it is unclear how SMC BMAL1 is involved. To elucidate the mechanisms underlying the SMC BMAL1's involvement, we first investigated whether BMAL1 mRNA is increased in older mice compared with younger mice thus potentially contribute to the increased susceptibility of older mice to DOCAsalt-induced AAA. We determined and compared the BMAL1 mRNA abundance in aortas from 4-month-versus 10-monthold WT C57BL/6J mice. Surprisingly, we found a slight but significant decrease in BMAL1 mRNA in the aortas from 10-month-old mice compared with those from 4-month-old mice (0.089±0.014 versus 0.133±0.013; n=5-6; P<0.05). We then investigated whether BMAL1 mRNA was increased by DOCA-salt in aorta from 8-month-old C57BL/6J mice. Using a specific BMAL1 antibody that we recently developed, 19 we found that BMAL1 protein was upregulated in aorta 21 days after DOCA-salt administration ( Figure 5A ). To investigate whether DOCA-salt-induced BMAL1 upregulation precedes AAA, we determined BMAL1 mRNA abundance in aorta 7 days after DOCA-salt administration and found that BMAL1 mRNA abundance was increased by 6-fold in aortas from mice administered with DOCA-salt compared with that in control mice ( Figure 5B ).
TIMP4 Was Identified as a New Target of BMAL1 in Aorta
To identify the molecular mechanism by which deletion of BMAL1 in SMCs upregulates TIMP4 mRNA and protein, we tested the possibility that BMAL1 binds directly to Timp4 gene promoter and suppresses its transcription.
First, we analyzed the mouse Timp4 promoter DNA sequence and identified several canonical E-boxes (CANNTG, where n can be any nucleotide) that are potential binding sites for BMAL1 ( Figure 6A ). To determine whether BMAL1 binds to these putative E-boxes, we performed chromatin immunoprecipitation assays in aortas from WT mice. The results showed that BMAL1 bound to the Timp4 promoter at E-box 2 through E-box 7 except for E-box 5 ( Figure 6B) . Second, to investigate whether binding of BMAL1 to the Timp4 promoter regulated its activity, we cloned a 2-kb mouse Timp4 promoter, inserted it into a luciferase reporter vector (pGl3-Timp4P-luc), and transfected the pGl3-Timp4P-luc construct into aortic VSMCs isolated from SM-Bmal1 −/− mice and WT littermates. In WT cells, the Timp4 promoter exhibited a 6-fold increase in luciferase activity over the pGL3 luciferase vector ( Figure 6C ). In contrast, when transfected into in BMAL1-deficient cells, the Timp4 promoter activity was further increased by 9-fold over that in WT cells (Figure 6D ), suggesting that Timp4 transcription is suppressed by BMAL1 in WT cells. BMAL1-deficient cells were verified by quantification of BMAL1 mRNA ( Figure 6E ) and protein ( Figure 6F ) expression levels.
Third, to investigate whether the observed BMAL1-mediated Timp4 transcriptional suppression translated to its mRNA suppression, we determined Timp4 mRNA expression in WT and BMAL1-deficient cells. We found that Timp4 mRNA was 27-fold higher in BMAL1-deficient cells than in WT cells ( Figure 6G ), suggesting that BMAL1 suppresses Timp4 promoter activity and mRNA expression in cultured VSMCs.
BMAL1 Was Implicated in DOCA-Salt-Induced Apoptosis and Neutrophil Infiltration in Aorta
BMAL1 has been shown to regulate apoptosis and inflammation in atherosclerosis and its complications. 32 Because apoptosis and inflammation also play pivotal roles in aortic aneurysm, 1 we explored whether deletion of BMAL1 in SMCs, in addition to upregulating TIMP4 and inhibiting MMP activity, is also involved in DOCA-salt-induced apoptosis and neutrophil infiltration in mouse aorta.
Aortas were isolated from 10-month-old male SM-Bmal1 −/− mice and WT littermates 10 days after DOCAsalt administration. Apoptotic cells were detected by a TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) kit. In accordance with our previous report, To define a potential role of SMC BMAL1 in DOCA-saltinduced vascular inflammation, we determined neutrophil infiltration by immunohistological analysis of aortic cross-sections with a rabbit anti-mouse PMN (polymorphonuclear leukocyte) antibody. We found that 10 days after DOCA-salt administration, PMN-positive cells were significantly increased only in aortas from the WT littermates but not SM-Bmal1 −/− mice and WT littermates before and 3 wk after PCSK9.AAV injection, Western diet feeding, and Ang II infusion. Two-way ANOVA followed by Bonferroni post hoc analysis was used for statistical analysis in A (n=6-14) and E (n=12-15). Two-way repeated measure ANOVA followed by Bonferroni post hoc analysis was used for statistics in B. Unpaired t test was used for statistics in C. χ 2 was used for comparing AAA incidence in D. ns indicates nonsignificant. *P<0.05, **P<0.01, ***P<0.00. Taken together, these results suggest that inhibiting apoptosis and neutrophil infiltration can also contribute to the protective effects of BMAL1 deletion in SMCs on AAA.
Deletion of BMAL1 in SMCs Potently
Protected Hypercholesterolemia Mice From Ang II-Induced AAA To test whether the protective effect of SMC BMAL1 deletion on AAA is only effective in the specific Aldo-or DOCA-salt-induced AAA model, we investigated whether SM-Bmal1 −/− mice are also protected from Ang II-induced AAA in hypercholesterolemia condition. We recently reported that injection of normocholesterolemic C57BL/6J mice with an AAV expressing a gain-of-function mutation of mouse PCSK9D377Y increased Ang II-induced AAA. 20 To induce hypercholesterolemia, 4-month-old male SM-Bmal1 −/− mice and WT littermates were IP injected with AAV-PCSK9D377 and fed a Western diet. In agreement with our previous report, 20 plasma cholesterol concentration was drastically elevated in WT littermates 3 weeks after AAV-PCSK9D377 injection and Western diet feeding, which maintained high concentrations throughout the subsequent 8 weeks of the experiments ( Figure 7A ). Importantly, there was no difference in the plasma cholesterol concentrations between SM-Bmal1 −/− mice and WT littermates, suggesting that deletion of BMAL1 in SMCs did not affect cholesterol homeostasis.
To define a role of SMC BMAL1 in Ang II-induced AAA in hypercholesterolemia mice, 26 (of 27) mice that had cholesterol >250 mg/dL were infused with Ang II for 8 weeks, which induced dilation of the abdominal aorta in WT littermates in a time-dependent manner ( Figure 7B) . Importantly, such abdominal aorta dilations were significantly attenuated in SM-Bmal1 −/− mice. To test the possibility that AAA may occur at a later stage in SM-Bmal1 −/− mice, we prolonged the Ang II infusion interval from 4 to 8 weeks by replacing the osmotic minipump after 4 weeks. The results show that maximal intraluminal abdominal aorta diameters were continually increased in a time-dependent manner in WT littermates but not in SM-Bmal1 −/− mice ( Figure 7B ). Infusion of WT littermates with Ang II also caused a large increase in maximal external diameter of the abdominal and thoracic aortas ( Figure 7C ), 100% AAA, 62% TAA, and 27% aneurysmal rupture ( Figure 7D ; Figure IX in the online-only Data Supplement), which were either abolished or significantly diminished in SM-Bmal1 −/− mice. The protection from AAA provided by BMAL1 deletion was unlikely attributable to its effect on blood pressure because Ang II infusion increased blood pressure to similar extents in SM-Bmal1 −/− mice and WT littermates ( Figure 7E ). Taken together, these results indicate that BMAL1 deletion from SMCs provides similar robust protection from AAA in divergent mouse models.
Discussion
The current study reports an unexpected pronounced protection of mice from aortic aneurysms induced by both DOCA-or Aldo-salt and Ang II infusion in hypercholesterolemia mice by deletion of BMAL1 in SMCs. The protection is associated with inhibition of elastin breakage, upregulation of TIMP4 mRNA and protein, and inhibition of apoptosis and neutrophil infiltration in mouse aortas.
BMAL1 has been implicated in several vascular pathologies; however, whether BMAL1 is involved in aortic aneurysm formation has not been investigated previously. Using an SMC-specific BMAL1 knockout mouse model, we recently demonstrated that SMC BMAL1 is essential for normal amplitude, time-of-day variations in vascular smooth muscle contraction, and normal blood pressure circadian rhythm. 19 Moreover, BMAL1 has been shown to be altered in aortas from diabetes mellitus and obesity [33] [34] [35] and in cultured VSMCs isolated from human atherosclerotic tissue. 36 The current study provides direct evidence that SMC BMAL1 is essential in MR agonist, DOCA, or aldosterone, plus salt-induced AAA, as well as Ang II-induced AAA in hypercholesterolemia mice.
Global deletion of BMAL1 in mice caused impaired vascular structural remodeling in response to blood flow reduction, 10 increased vascular expression and activity of MMP2 and 9, 11 and increased vascular superoxide and endothelial NO synthase uncoupling, 13, 37 suggesting detrimental vascular effects of global BMAL1 deletion. However, global BMAL1 knockout mice were used in these studies; the observed vascular phenotypes, therefore, may result from the loss of vascular BMAL1 or alternatively from the systemic disruptions caused by deleting BMAL1 from multiple systems. A subsequent elegant study demonstrated that an aortic graft from BMAL1 −/− mice transplanted into littermate WT mice developed robust arteriosclerotic disease with upregulation of T-cell receptors, macrophages, and infiltrating cells, 12 suggesting that vascular BMAL1 deletion alone has detrimental effects. In this context, it was surprising that the current study found that, in contrast to this transplant model, deletion of BMAL1 in SMCs provides effective protection from both DOCA-or Aldo-salt and Ang II-induced aortic aneurysm. Although the precise mechanisms underlying such discrepancy remain unclear, we speculate that it may be because of cell-specific consequences of BMAL1 deletion. Detrimental effects of deleting BMAL1 from endothelial cells or adventitial fibroblast cells may be dominant and mask beneficial effects of the SMC BMAL1 deletion in the aorta transplant experiment. 12 A recent study found that inducible global BMAL1 deletion protected mice from atherosclerosis, suggesting significant embryonic development effects of BMAL1 may be involved as well. 38 One of novel findings from the current study is that deletion of BMAL1 in SMCs selectively upregulated TIMP4, which likely mediates, at least in part, inhibition of MMP and decrease of elastin breakage. MMP activity is critical for the pivotal elastin breakage step in the aorta dilation process during aneurysm development. TIMP is one determinant of the final MMP activity by forming tight 1:1 complexes with activated MMPs, inhibiting their enzymatic activity. Therefore, TIMPs may play an important role in aortic aneurysm. Indeed, loss of TIMP1 or TIMP3 enhanced AAA in response to elastase 39 or Ang II infusion. 40 Local overexpression of TIMP1 prevents aortic aneurysm in orthotopically graft rat aneurysm model. 41 These results suggest a protective role of TIMPs in aortic aneurysm. However, a precise role of TIMPs in the aortic aneurysm pathogenesis can be animal model specific and TIMP isoform specific because targeted deletion of TIMP2 results in attenuation, rather than enhancement, of CaCl 2 -induced aneurysm development. 42 To the best of our knowledge, a role of TIMP4 in aortic aneurysm has not been reported. Moreover, the role of TIMPs in the DOCA-or Aldo-salt-induced aortic aneurysm model has not been reported. The current study provided several novel insights into these 2 important issues. First, the mRNA of Timp4, among the 4 TIMPs, is selectively upregulated in aorta from SM-Bmal1 −/− mice under basal and 7 and 21 days after DOCA-salt administration. Second, such in vivo Timp4 mRNA upregulation can be manifested by ex vivo aortic organ culture and in vitro VSMC culture, suggesting that increased Timp4 mRNA abundance occurs mainly in aortic VSMC. Consistent with this possibility, a drastic TIMP4 protein upregulation occurred in the medial aortic layer and the culture medium of aortic organ culture. Third, we identified TIMP4 as a novel target of BMAL1 in SMCs. Although the 4 members of the TIMP family inhibit secreted MMPs with roughly comparable potencies, 43, 44 individual TIMPs differ markedly in their pro-MMP interaction, gene regulatory mechanisms, and biochemical properties.
31 Timp4 promoter lacks a classical TATA-box sequence and contains relatively few identifiable transcription factor-binding consensus motifs. 45 Vascular TIMP4 is upregulated after balloon injury. 46 A recent study reported that Timp4 is a direct transcriptional target of PPARγ in VSMCs. 47 Along with these studies, the current study demonstrated that BMAL1 bound to the Timp4 promoter via E-boxes, and deletion of BMAL1 in SMCs resulted in increased Timp4 promoter activity and mRNA expression, indicating that BMAL1 binds and suppresses Timp4 transcription in this cell type.
Our observations that SMC BMAL1 is also involved in DOCA-salt-induced apoptosis, caspase 3 activation, and neutrophil infiltration in aortas, which is consistent with the scenario that multiple mechanisms, in addition to targeting TIMP4, mediate the protection from AAA by SMC BMAL1 deletion. However, further studies are required to fully address these potentially important mechanistic issues.
